Results 271 to 280 of about 126,024 (329)

New Quinazolin-4(3<i>H</i>)-one Derivatives as Potential Antitumoral Compounds: Synthesis, In Vitro Cytotoxicity Against the HepG2 Cell Line, and In Silico VEGFR-2 Targeting-Based Studies. [PDF]

Molecules
Pele R, Marc G, Tiperciuc B, Ionuț I, Stana A, Moldovan C, Tatomir C, Dragostin OM, Pîrnău A, Vlase L, Ungureanu D, Oniga O.   +11 more
europepmc   +1 more source

Cytotoxic Effects of Sorafenib, Lapatinib, and Bevacizumab, Alone and in Combination, on Medullary Thyroid Carcinoma Cells. [PDF]

Curr Oncol
Altun G, Yönem Ö.
europepmc   +1 more source

Combined Immunotherapy in Treating Patients with Advanced Hepatocellular Carcinoma. [PDF]

Biomedicines
Li KHL, Leung R, Li BCW, Cheung TT, Yau T.   +4 more
europepmc   +1 more source

Integrating FLT3-ITD molecular features with clinical risk factors improves risk stratification in acute myeloid leukemia. [PDF]

Ann Hematol
Zhang K, Ma X, Lu X, Ruan G, Wei F, Jiang H, Chang Y, Huang X, Zhao X.   +8 more
europepmc   +1 more source

Efficacy and safety of sorafenib combined with transarterial chemoembolization in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. [PDF]

Front Oncol
Yu L, Xiong Y, Liao J, Deng Y, Zhai X.
europepmc   +1 more source

Retrospective analysis of sorafenib combined with interferon α-1b, interleukin-2, and thalidomide as maintenance therapy in FLT3-ITD-positive acute myeloid leukemia. [PDF]

Front Oncol
Cheng C, Mi R, Li D, Chen L, Wei X.
europepmc   +1 more source

The Combination Therapy With Sorafenib in Therapeutic Strategy of Acute Myeloid Leukemia. Is It Promising? A Narrative Review. [PDF]

Health Sci Rep
Shamahmood MN, Miri A, Mezginejad F.
europepmc   +1 more source

Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM). [PDF]

iScience
Kalkavan H, Scheulen ME, Kämpgen E, Keilholz U, Heinzerling L, Lueong SS, Hlinka A, Gromke T, Ochsenreither S, Hilger RA, Grubert M, Wetter A, Guberina N, Zeschnigk M, Ferency P, Held S, Hinke A, Schuler G, Al-Ghazzawi K, Bornfeld N, Bechrakis NE, Schuler M, Bauer S, Richly H, Siveke JT.   +24 more
europepmc   +1 more source

Adrenomedullin orchestrates treatment resistance in hepatocellular carcinoma via immune microenvironment remodeling. [PDF]

Front Genet
Gao X, Sun Y, Huang J, Xu L, Huang H, Yang Z.   +5 more
europepmc   +1 more source